Jennifer Ng

Title: The Innovative Contributions of Jennifer Ng

Introduction

Jennifer Ng is a prominent inventor based in New York, NY, known for her significant contributions to cancer research. She has developed a patent that plays a crucial role in the detection and differentiation of cancerous cells. Her work is particularly focused on human teratocarcinomas, which are a type of cancer that can be challenging to diagnose.

Latest Patents

Jennifer Ng holds a patent for "Monoclonal antibodies to cell surface antigens of human teratocarcinomas." This patent describes antibody-producing hybridoma cell lines created by fusing NS/1 cells with spleen cells of mice that have been immunized with human teratocarcinoma cells. The monoclonal antibodies derived from these cell lines are capable of recognizing the K4, K2, and P12 antigenic systems. This innovation is particularly useful in the pathologic analysis of human tumors, especially teratocarcinomas, aiding in the detection and differentiation between normal and cancerous cells.

Career Highlights

Jennifer Ng is affiliated with the Sloan Kettering Institute for Cancer Research, where she continues her groundbreaking work in cancer research. Her dedication to advancing medical science has made her a valuable asset in the field.

Collaborations

Jennifer has collaborated with notable colleagues, including Wolfgang J. Rettig and Carlos Cordon-Cardo. These partnerships have further enhanced her research and contributions to the scientific community.

Conclusion

Jennifer Ng's innovative work in developing monoclonal antibodies has made a significant impact on cancer research and diagnosis. Her contributions continue to advance the understanding and treatment of teratocarcinomas, showcasing the importance of innovation in the medical field.